MEPs reject US-style direct advertising of drugsBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7371.990/a (Published 02 November 2002) Cite this as: BMJ 2002;325:990
- Rory Watson
Members of the European parliament have categorically rejected tentative plans to allow pharmaceutical companies to provide information on drugs directly to the public in the European Union.
As part of its proposals to update existing EU legislation on the approval and marketing of drugs, the European Commission had suggested a five year pilot scheme during which firms could supply data directly to patients on three common illnesses: diabetes, asthma, and AIDS.
Erkki Liikanen, the European commissioner behind the proposal, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial